Eulav Asset Management Charles River Laboratories International, Inc. Transaction History

Eulav Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $249,670 - $299,480	1,000 Added 6.25%	17,000 $4.93 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $2.22 Million - $2.53 Million	10,000 Added 166.67%	16,000 $4 Million
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $713,040 - $1.14 Million	6,000 New	6,000 $1.05 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.